undefined undefined
NaN.000
NaN.00%
西南证券股份有限公司杜向阳近期对春立医疗进行研究并发布了研究报告《业绩短期承压,后集采时代有望迎来恢复性增长》,本报告对春立医疗给出买入评级,当前股价为18....
03-29 19:50
Benchmark analyst Bruce Jackson maintains Biolase (NASDAQ:BIOL) with a Speculative Buy and lowers the price target from $2.5 to $0.4.
03-23 01:42
BIOLASE, Inc. shares rise 31% after better-than-expected FY23 EPS results, strong revenue growth expected in 2024 due to increased laser adoption.
03-22 23:13
U.S. stocks traded slightly lower this morning. Following the market opening Friday, the Dow traded down 0.06% to 39,758.88 while the NASDAQ fell 0.10% to 16,385.60. The S&P 500 also fell, dropping, 0.01% to 5,241.33.
03-22 21:45
Biolase shares are trading higher after the company reported better-than-expect...
03-22 04:27
Biolase (NASDAQ:BIOL) reported its Q4 earnings results on Thursday, March 21, 2...
03-22 04:20
Biolase (NASDAQ:BIOL) reported quarterly losses of $(1.76) per share which beat the analyst consensus estimate of $(2.55) by 30.98 percent. This is a 98.63 percent increase over losses of $(128.00) per share from the
03-22 04:16
Companies Reporting Before The Bell • Creative Realities (NASDAQ:CREX) is expected to report quarterly earnings at $0.02 per share on revenue of $16.47 million.
03-21 18:15
Major earnings expected after the bell on Thursday include: NIKE (NKE) FedEx Corporation (FDX) Lululemon Athletica (LULU) Asensus Surgical (ASXC) AAR Corp. (AIR) Other earnings slated for release afte...
03-21 05:35
Biolase (NASDAQ:BIOL) is set to give its latest quarterly earnings report on Th...
03-21 01:00